Five Problems Private Label Solves in Industrial Hand Protection

National-brand gloves still belong in a serious U.S. program. They carry published data, recognition, and an easier first conversation with a conservative safety manager. They do not, however, fix the five structural problems that keep showing up in distributor P&Ls and plant glove matrices: supply volatility, generic branding, compliance gaps, high costs, and a catalog that was not built for the actual hazard.

Private label is not a sticker on a cheaper glove. Done correctly, it is a sourcing and specification model that puts the distributor — and the end-user program — in control of those five problems. The U.S. industrial hand-glove market is growing at roughly 5.4% CAGR through 2035, driven by regulation and injury cost, not by more SKUs of the same national brand. The value in that growth is going to the programs that can specify, stock, and document the glove, not only resell it.

1. Supply volatility

Industrial hand protection is a globally sourced category sitting on a volatile raw-material and trade stack. Nitrile butadiene latex prices move with petrochemicals. Ocean freight and port congestion reprice landed cost between the quote and the container. And U.S. tariff policy has redrawn origin economics more than once since 2025.

Disposable glove import tariffs have ranged widely by origin, with Chinese medical and surgical gloves facing a further step-up to 100% from January 2026 after a 50% rate. Industrial glove duties are not identical, but Section 301 and MFN layers have still pushed many buyers toward a China-plus-one model - Malaysia, Vietnam, Indonesia - only for Chinese-backed capacity to follow the tariff. AMMEX’s 2025 market review described the U.S. disposable glove market as volatile but resilient: tariffs, logistics, and raw-material costs all moved pricing, and spot buying was the riskiest channel. Reusable cut and chemical gloves follow the same pattern with a longer lead time and a narrower set of qualified mills.

National-brand distribution adds a second layer of volatility. Allocation during a shortage follows the brand’s priorities, not the distributor’s book of business. A specified A5 foam-nitrile can go on allocation while the plant still has the task. Substitutions arrive with someone else’s part number and, too often, a different coating or gauge.

Private label does not eliminate trade risk. It changes who manages it.

• Dual-origin builds. A house line can be qualified at two mills - for example a China plant and a Southeast Asia plant - against the same ANSI/ISEA 105 report and the same construction. When one origin is tariffed or delayed, the other can ship the same spec.
• Owned forecast. Core SKUs (the A2–A4 handling glove, the A5–A6 metal glove, the chemical pair) are held at a defined weeks-of-cover. Fill rate is a distributor decision, not a supplier scorecard.
• Contracted volume. Blanket orders with scheduled releases lock capacity that spot national-brand buys cannot. First production after sample approval commonly runs 30–60 days; after that, restocks are a planning problem, not a scramble.
• Documented substitution. If a yarn or coating must change, the change is retested and the customer matrix is updated. “Equivalent” is a tested claim.

The trade-off is working capital and minimums. Larger orders are required to be able to lock in the control and ensure consistency of supply. That is the price of not being last in someone else’s allocation queue.

2. Generic branding

Once two distributors sell the same manufacturer part number, the buyer can price-shop it in minutes. Rebate, freight, and who blinks first become the entire negotiation. The glove may be excellent. The commercial relationship is generic.

Private label stops the identical-SKU comparison. It does not stop technical comparison - and it should not. A competent safety manager will still ask for the ASTM F2992 cut score, abrasion cycles, and puncture level. What changes is that the competitor cannot undercut a published national part number on their website by a dollar and call it the same item.

Differentiation that holds in B2B safety is operational, not cosmetic:

• A good / better / best architecture mapped to hazard bands, not to a factory’s leftover colors.
• Consistent ANSI/ISEA 105-2024 pentagon marking — cut at the top, abrasion left, puncture right — so the label matches the matrix.
• Task color-coding (yellow for light assembly, orange for metal, green for chemical splash) that supervisors can audit from across the floor.
• Size runs that include smaller and extended sizes, which matters more after OSHA’s construction PPE fit rule (29 CFR 1926.95(c), effective January 13, 2025) made proper fit an explicit requirement.

McKinsey’s work on distributor private label is blunt: these products can carry about twice the gross margin of comparable national-brand SKUs, and a large majority of B2B buyers say they plan to buy more distributor-branded product. BCG has put the gross-margin gap at 15–30 percentage points. That spread exists because the distributor owns price architecture and because the item cannot be identically matched. It disappears if the house brand is just a logo on an undifferentiated commodity.

3. Compliance gaps

OSHA 29 CFR 1910.138 is short and performance-based. Employers must select hand protection based on the glove’s performance characteristics relative to the task, conditions, duration, and hazards - cuts, abrasions, punctures, chemicals, heat. 1910.132 still requires a hazard assessment, training, and employer payment. The construction fit rule aligned 1926.95(c) with that general-industry expectation.

The gap is not the absence of a glove in the cage. It is the mismatch between what was assessed and what is on the hand.

Common failure modes:

• A catalog icon that says “cut resistant” with no A-level, or an old proprietary mark that does not map to ANSI/ISEA 105-2024.
• A substitution during a shortage that changes gauge or coating without a new test report.
• One size stocked for a mixed workforce, so the glove is removed for dexterity — the same mechanism behind the long-cited split in which roughly 70% of workers with hand injuries were not wearing gloves and 30% were wearing gloves that were inadequate or wrong for the hazard.
• No lot-level documentation when a compliance officer or insurer asks how the selection was justified.

ANSI/ISEA 105-2024 did not rewrite the A1–A9 cut scale. It standardized how performance is displayed and tightened the language for demonstrating conformity, pointing to ANSI/ISEA 125. The pentagon exists so buyers can compare. It only works if the incoming product is current, tested, and labeled honestly — including an “X” where a property was not tested.

Private label closes the gap only if the distributor accepts the compliance workload the brand owner used to carry:

• Independent testing to ASTM F2992 (TDM-100) for cut, and the relevant abrasion and puncture methods, with the report shipped with the goods.
• Labeling to the 2024 pictogram, and correct reference language (ANSI/ISEA 105-2024, not “ANSI cut”).
• A written matrix that names the house SKU, the hazard, the rating, and the approved substitution.
• Incoming QC and a change-control rule: no construction change without a retest.
• Size availability that supports the fit obligation, not only L and XL.

That workload is the moat. A reseller who only forwards a national brand’s PDF cannot copy a qualified, documented house spec overnight. It is also the liability. If the claim on the cuff is wrong, the distributor owns it.

4. High costs

“High costs” in this category are usually two different numbers that get conflated.

The first is unit price. Domestic distributor pricing on standard nitrile often sits 20-40% above own brand at container volume. Specialty constructions - higher-gauge industrial nitrile, HPPE/glass cut knits, supported chemical gloves - carry a wider spread because price transparency is lower. A private-label pair can sell below the national brand and still increase dollar margin. 

The second number is total cost of ownership, and it is the one plant finance actually feels. Average hand and wrist workers’ compensation settlements sit near $29,000, with fractures, tendon repairs, and finger amputations running much higher. Indirect cost - replacement labor, overtime, investigation, lost output - routinely exceeds the medical invoice. A cheaper glove that is removed, that fails in days, or that is the wrong cut level is not cheaper. Private label attacks both numbers: landed cost on the core, and consumption plus injury cost when the spec matches the task and the size matches the hand.

Costs private label does not magically remove:

• Tooling, artwork, and first-article lab testing, often thousands in year one depending on SKU count.
• Higher MOQs and multiple weeks of cover on core items.
• QA and compliance time, typically a fraction of an FTE once the program is running.

With MAXD, we cover sections of the above to ensure your stock is cheaper to own, fit for purpose and will ensure no disruption on your supply.

5. Lack of customization

National catalogs are built for a national average. A fabricator’s edge hazard, a food plant’s blade-and-sanitizer mix, a warehouse’s need for touchscreen dexterity at A3, and a utility crew’s need for abrasion plus impact are not the same glove. Buying the closest catalog SKU and calling it specified is how programs accumulate rogue items and unused pairs.

Private label is where the spec is written to the book of business:

Sampling is commonly 7–15 days; custom development a few weeks beyond that; mass production often 25–60 days from approved sample depending on construction. That lead time is acceptable for a core program. It is not acceptable as the only source for an emergency fill - which is why a hybrid catalog (house brand on the stable core, national brand on mandated or low-velocity SKUs) is the operating model that actually works.

Customization also has a limit. A one-off glove for a 12-person cell will not clear a sensible MOQ. The right unit of customization is the task family that repeats across sites, not every work order.

What private label does not solve

It does not remove the need for a hazard assessment. It does not make workers wear a glove that destroys dexterity. It does not protect a distributor who skips factory qualification and lets a trader rotate mills between orders. And it raises, rather than lowers, the documentation burden: labeling review, test reports, change control, and recall readiness sit with the brand owner.

Those are reasons to run private label as a controlled program, not reasons to avoid it.

The operating conclusion

Supply volatility is managed by qualified dual origin and owned inventory, not by hoping a national brand allocates fairly. Generic branding is managed by a spec the competitor cannot quote by part number. Compliance gaps are managed by 2024 labeling, independent test data, and a matrix that names the SKU. High cost is managed as landed cost plus cost per protected hour, not as the last bid sheet. Lack of customization is managed by writing the construction to the hazard bands the distributor actually sells.

For U.S. distributors, the five problems are the business case. For WHS and compliance managers, they are the reason a house brand can be named in the written assessment — provided the test report, the size run, and the fill rate are real. Private label solves those problems only to the extent the program is specified, tested, stocked, and worn. That is a higher bar than resale. It is also the only bar that matches how 1910.138 is actually enforced.